About this trial
The purpose of this study is to evaluate overall changes in patient management and longer-term resource utilization between control and test arms, including (but not limited to) additional work-up (including other diagnostic tests and consults), antimicrobial treatments, disposition decisions and hospital length of stay (LOS)
Eligibility criteria
Qualifiers
Current disease duration ≤ 7 days
Temperature ≥ 37.8°C (100°F) or tactile fever, noted at least once within the last 7 days
Clinical suspicion of bacterial or viral respiratory tract infection (RTI)
Disqualifiers
Systemic antibiotics taken up to 48 hours prior to presentation
Outpatient steroids taken within 48 hours prior to presentation
Suspicion and/or confirmed diagnosis of infectious gastroenteritis/colitis
Inflammatory disease
Trial design
Treatments tested in this trial
- MeMed BV® biomarker test
- Usual care
Treatment groups
Sponsors and collaborators
The University of Texas Health Science Center, Houston
Lead sponsor
MeMed Diagnostics Ltd.
Collaborator